¼¼°èÀÇ ÀÏ·¹¿À½ºÅä¹Ì ½ÃÀåÀº 2024³â 12¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025-2034³â±îÁö CAGR 5%·Î ¿¹ÃøµÇ¾î ²ÙÁØÇÑ ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå È®´ë´Â À§ÀåÀå¾ÖÀÇ À¯º´·ü Áõ°¡, ¿ËÈ£ ÇÁ·Î±×·¥À» ÅëÇÑ ÀÇ½Ä Áõ°¡, ÀçÅà Äɾî Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ °æÇâ Áõ°¡¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¼ÓÀûÀÎ ÀÇ·á Áøº¸¿Í ¼ö¼ú ±â¼úÀÇ Çâ»óÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÏ·¹¿À½ºÅä¹Ì ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀåÀº ¿£µå ÀÏ·¹¿À½ºÅä¹Ì¿Í ·çÇÁ ÀÏ·¹¿À½ºÅä¹ÌÀÇ À¯ÇüÀ¸·Î ºÐ·ùµÇ¸ç, ¿£µå ÀÏ·¹¿À½ºÅä¹Ì ºÎ¹®ÀÌ ¼ºÀåÀ» À̲ø°í CAGR 5.2%¿¡¼ 2034³â±îÁö 15¾ï ´Þ·¯¸¦ ´Þ¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º¹°°æ ¼ö¼úÀ̳ª ·Îº¿ Áö¿ø ¼ö¼ú µîÀÇ Àúħ½À ¼ö¼ú·Î Á¾¸» ÀÌ·ç¿ì½º ´©°øÀº º¸´Ù ÀÌ¿ëÇϱ⠽¬¿öÁö°í, ȸº¹ ½Ã°£À» ´ÜÃàÇϰí, ȯÀÚÀÇ ¼ö¿ë¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ƯÈ÷ ¿µ±¸ÀûÀÎ ¼ö¼ú ¼Ö·ç¼ÇÀ» Ãß±¸Çϴ ȯÀÚ¿¡°Ô ¿£µå ÀÏ·¹¿À½ºÅä¹Ì°¡ Á¡Á¡ ¼±È£ÇÏ´Â ¿É¼ÇÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 12¾ï ´Þ·¯ |
¿¹Ãø ±Ý¾× | 20¾ï ´Þ·¯ |
CAGR | 5% |
Á¦Ç°º°·Î, ÀÏ·¹¿À½ºÅä¹Ì ½ÃÀåÀº ¿À½ºÅä¹Ì °¡¹æ°ú ¾×¼¼¼¸®·Î ³ª´µ¸ç, ¿À½ºÅä¹Ì °¡¹æ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÎ¹®Àº 2034³â±îÁö 17¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿À½ºÅä¹Ì ¹é ¼ö¿ä Áõ°¡´Â ÀÏ·¹¿À½ºÅä¹Ì, Àΰø Ç×¹® ¶Ç´Â ¿ì·Î½ºÅä¹Ì Ä¡·á¸¦ ¹Þ´Â ȯÀÚÀÇ ¹è¼³¹° °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒ¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇʼöÀûÀÎ Á¦Ç°Àº È¿°úÀûÀÎ ¼ö¼ú ÈÄ °ü¸®¸¦ Á¦°øÇÔÀ¸·Î½á »îÀÇ ÁúÀ» Å©°Ô Çâ»ó½Ãŵ´Ï´Ù. °Ô´Ù°¡, ´ëÀå¾Ï, Å©·Ðº´, ±Ë¾ç¼º ´ëÀå¿°, °Ô½Ç¿°ÀÇ ÀÌȯÀ² »ó½ÂÀº ¿À½ºÅä¹Ì ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ °è¼Ó ºÎÃß°Ü ¿À½ºÅä¹Ì Á¦Ç° ½ÃÀåÀ» ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù.
¹Ì±¹¿¡¼ ÀÏ·¹¿À½ºÅä¹Ì ½ÃÀåÀº 2024³â¿¡ 2¾ï 2,840¸¸ ´Þ·¯ÀÇ ¼öÀÍÀ» âÃâÇßÀ¸¸ç 2034³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 3.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ´ëÀå¾ÏÀÇ ÀÌȯÀ²ÀÇ ³ôÀÌ¿Í °ü·ÃµÈ ´ëÀå ÀýÁ¦ ¼ö¼úÀÌ ÀÏ·¹¿À½ºÅä¹Ì¿Í Àΰø Ç×¹® Äɾî Á¦Ç° ¼ö¿ä Áõ°¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¸¸¼º À§Àå Áúȯ¿¡ °É¸®±â ½¬¿î °í·ÉÈ »çȸ´Â Àå±âÀûÀÎ ¿À½ºÅä¹Ì °£È£ ¼Ö·ç¼ÇÀÇ Çʿ伺À» ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ Å©·Ðº´ ¹× ±Ë¾ç¼º ´ëÀå¿°ÀÇ À¯º´·ü Áõ°¡µµ ¹Ì±¹ ½ÃÀåÀ» °ßÀÎÇÏ´Â Áß¿äÇÑ ¿äÀÎÀ̸ç, ÀÌ·¯ÇÑ ÁúȯÀº È¿°úÀûÀÎ Ä¡·á¸¦ À§ÇØ Á¾Á¾ ÀÌ·¹¿ì½º ´©Á¶¼³¼úÀÌ ÇÊ¿äÇÕ´Ï´Ù.
The Global Ileostomy Market was valued at USD 1.2 billion in 2024 and is expected to experience steady growth, with a projected CAGR of 5% from 2025 to 2034. The expansion of the market can be attributed to the increasing prevalence of gastrointestinal disorders, rising awareness through advocacy programs, and the growing trend toward homecare treatment solutions. Additionally, continuous advancements in healthcare and improved surgical techniques are enhancing patient outcomes, further propelling the growth of the ileostomy market.
The market is categorized into end ileostomy and loop ileostomy types, with the end ileostomy segment anticipated to lead the growth, achieving a value of USD 1.5 billion by 2034 at a CAGR of 5.2%. Minimally invasive procedures, such as laparoscopic and robotic-assisted surgeries, are making end ileostomies more accessible, reducing recovery times and boosting patient acceptance. These innovations have positioned end ileostomy as an increasingly preferred option, especially for patients seeking permanent surgical solutions.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $1.2 Billion |
Forecast Value | $2 Billion |
CAGR | 5% |
In terms of products, the ileostomy market is divided into ostomy bags and accessories, with the ostomy bags segment holding the largest market share. This segment is projected to reach USD 1.7 billion by 2034. The growing demand for ostomy bags is driven by their vital role in waste management for patients undergoing ileostomy, colostomy, or urostomy procedures. These essential products greatly improve the quality of life by providing effective post-surgical care. Furthermore, the rising incidence of colorectal cancer, Crohn's disease, ulcerative colitis, and diverticulitis continues to fuel the demand for ostomy surgeries, further boosting the market for ostomy products.
In the U.S., the ileostomy market is expected to generate USD 228.4 million in revenue in 2024 and grow at a CAGR of 3.6% through 2034. The high incidence of colorectal cancer and related colectomy surgeries has significantly contributed to the growing demand for ileostomy and colostomy care products. Additionally, the aging population, which is more susceptible to chronic gastrointestinal conditions, further drives the need for long-term ostomy care solutions. The increasing prevalence of Crohn's disease and ulcerative colitis in the region is also a key factor driving the U.S. market, as these conditions often necessitate ileostomy procedures for effective treatment.